CK17
Alternative name:
Cytokeratin 17 (CK17, K17)
Methodology
Immunohistochemistry (IHC)
Test Description and clinical significance
Disease:
Invasive or in situ ductal carcinoma of breast , bladder carcinoma, pancreatobiliary adenocarcinoma, renal urothelial carcinoma, and cholangiocarcinoma
Basal type cytokeratin of complex epithelia but not in stratified or simple epithelia
Rapidly induced in wounded stratified epithelia, regulates cell growth through binding to the adaptor protein 14-3-3sigma
Specimen Requirements
Collection:
FFPE/un-stained slides/Fresh tissue in formalin
Stability:
Room temperature
Unacceptable Conditions:
Unlabeled specimen/specimen left unfixed
for extended periods
Storage & Transport
Room Temperature
CPT(s)
88342 if intial single stain or 88341 for each additional stain CK17
New York Approved
NO
TAT
1 Day
*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.
